How to Get Trazodone in Missouri

What Is Trazodone and Why Is It Prescribed?

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) the FDA first approved in 1981 for major depressive disorder. Its sedating properties made it one of the most frequently prescribed off-label sleep aids in the United States within a decade of approval. A 2014 analysis published in the Journal of Clinical Psychiatry estimated that off-label insomnia use accounted for the majority of all trazodone prescriptions written nationally.

At antidepressant doses (150 to 400 mg/day), trazodone blocks serotonin 5-HT2A receptors and inhibits serotonin reuptake. At the lower doses used for sleep (25 to 100 mg), the 5-HT2A antagonism and histamine H1 blockade dominate, producing sedation without the dependence risk associated with benzodiazepines or Z-drugs like zolpidem. A randomized controlled trial by Mendelson (2005, N=306) found trazodone 50 mg reduced subjective sleep latency by approximately 10 minutes versus placebo over the first two weeks of treatment, though the effect attenuated by week eight.

Because trazodone is not a scheduled substance under the DEA Controlled Substances Act, Missouri providers face fewer regulatory barriers when prescribing it compared to Schedule IV hypnotics like zolpidem or temazepam. This distinction matters for telehealth workflows in particular, where controlled-substance prescribing carries additional state and federal restrictions.

Who Can Prescribe Trazodone in Missouri?

Any Missouri-licensed prescriber with an active state license and a valid DEA registration (required even for non-controlled medications dispensed from certain settings) can write a trazodone prescription. This includes physicians (MD and DO), nurse practitioners, and physician assistants.

Missouri nurse practitioners operate under a collaborative practice agreement with a physician, though NPs with a graduate certificate in a psychiatric specialty routinely prescribe trazodone for both depression and insomnia. Physician assistants in Missouri prescribe under physician supervision per MO Rev Stat § 334.735. Neither NPs nor PAs face formulary restrictions specific to trazodone beyond their general scope.

For patients without an existing provider relationship, a single visit (in-person or via telehealth) is typically sufficient to obtain a trazodone prescription. The American Academy of Family Physicians (AAFP) recommends cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, with pharmacotherapy reserved for patients who do not respond or lack access to CBT-I. Missouri clinicians generally follow this framework, though many prescribe trazodone at the initial visit when insomnia is severe or when the patient also carries a depression diagnosis.

Telehealth Prescribing Rules in Missouri

Missouri law explicitly permits prescribing via telehealth. The state's telehealth statute, MO Rev Stat § 191.1145, defines a "telehealth encounter" as a real-time or store-and-forward interaction between a patient and a provider, and it allows prescriptions to be issued from such encounters without an in-person prerequisite.

Since trazodone is not a controlled substance, it falls outside the more restrictive requirements that Missouri applies to Schedule II through V drugs. A provider can evaluate a patient via synchronous video, document the clinical rationale, and transmit the prescription electronically to any Missouri pharmacy during the same encounter. The entire process, from scheduling to receiving the e-prescription at a pharmacy, often takes less than 48 hours.

Missouri-based telehealth platforms and national services licensed in the state both prescribe trazodone. When evaluating a telehealth provider, patients should confirm three things: the clinician holds an active Missouri license (verifiable through the Missouri Division of Professional Registration), the platform transmits prescriptions electronically to Missouri pharmacies, and the encounter includes a documented medical history and sleep assessment rather than a questionnaire-only interaction.

The American Telemedicine Association's practice guidelines recommend that telehealth mental health encounters include validated screening tools such as the PHQ-9 for depression or the Insomnia Severity Index (ISI) for sleep complaints. Missouri does not mandate specific screening instruments by statute, but using validated tools strengthens the clinical record and may be required by malpractice insurers.

What Labs Are Needed Before Starting Trazodone?

The FDA-approved prescribing information for trazodone does not mandate any specific laboratory tests before initiation. No routine blood monitoring is required during treatment either, which distinguishes trazodone from medications like lithium or clozapine that require ongoing lab surveillance.

Some Missouri clinicians order a baseline comprehensive metabolic panel (CMP) and thyroid-stimulating hormone (TSH) before prescribing trazodone, not because the drug demands it but to rule out metabolic causes of insomnia or depression. Hypothyroidism, for example, can present with both fatigue and depressed mood, and treating the underlying thyroid disorder may eliminate the need for trazodone entirely.

An electrocardiogram (ECG) is not routinely recommended for healthy adults starting low-dose trazodone. The drug can prolong the QT interval at higher doses, and the FDA label carries a warning about cardiac arrhythmias in patients with pre-existing cardiac disease. Clinicians may order an ECG for patients over 65, those with known cardiac conditions, or those taking other QT-prolonging medications. A 2018 review in the Journal of Clinical Psychopharmacology found that trazodone-associated cardiac events were rare at doses below 150 mg/day and occurred predominantly in patients with pre-existing conduction abnormalities.

Pharmacy Access and Pricing in Missouri

Generic trazodone hydrochloride tablets are stocked at virtually every retail pharmacy in Missouri. Walgreens, CVS, Walmart, Hy-Vee, and independent pharmacies across the state carry 50 mg and 100 mg tablets as standard inventory. The drug is available in 50 mg, 100 mg, 150 mg, and 300 mg tablet strengths, as well as an extended-release formulation (Oleptro) that is considerably more expensive.

Pricing for generic immediate-release trazodone is among the lowest of any prescription medication. Most Missouri pharmacies price a 30-day supply of trazodone 50 mg (quantity 30) between $4 and $15 without insurance. Walmart and several Missouri grocery-chain pharmacies include trazodone on their $4 generic lists. Patients paying cash should request pricing from the pharmacy directly or use a discount card, which can reduce the cost to under $10 in most cases.

The extended-release formulation, brand name Oleptro, costs substantially more ($200 to $400 per month without insurance) and is rarely prescribed for off-label insomnia. Missouri prescribers almost universally select the immediate-release generic for sleep indications.

503A Compounding Pharmacies in Missouri

Missouri licenses 503A compounding pharmacies under the state Board of Pharmacy. These pharmacies can compound trazodone into alternative dosage forms (liquids, flavored suspensions, lower-dose capsules) when a prescriber determines that commercially available formulations do not meet a patient's needs. A patient who cannot swallow tablets, for example, could receive a compounded trazodone oral solution.

Licensed 503A pharmacies in Missouri may ship compounded medications directly to patients within the state. The FDA's guidance on 503A compounding requires a valid patient-specific prescription, and Missouri's pharmacy board enforces additional record-keeping and quality standards. Patients should verify that any 503A pharmacy they use holds a current Missouri Board of Pharmacy license.

Compounded trazodone is not typically necessary for most patients, given the wide availability and low cost of the commercial generic. It becomes relevant when a specific dose (such as 12.5 mg or 75 mg) is needed and tablet splitting is impractical, or when a patient requires a liquid formulation.

Missouri Medicaid and Insurance Coverage

Missouri Medicaid (MO HealthNet) maintains a preferred drug list (PDL) that determines coverage. As of 2026, trazodone is not covered under MO HealthNet for depression or off-label insomnia indications. The Medicaid PDL currently limits certain psychiatric medication coverage categories, and trazodone falls outside the covered formulary for these diagnoses.

Private insurance plans sold in Missouri, including those on the ACA marketplace, almost universally cover generic trazodone with minimal cost-sharing. Most commercial plans place it on Tier 1 (preferred generic), resulting in copays of $0 to $10. Patients with private insurance should not need prior authorization for generic trazodone in most cases.

For uninsured Missouri residents, the low retail price of generic trazodone ($4 to $15) makes it one of the most affordable prescription medications available. Manufacturer patient assistance programs exist but are rarely needed given the generic cost. Community health centers and federally qualified health centers (FQHCs) across Missouri, including those participating in the 340B Drug Pricing Program, can provide trazodone at reduced prices.

Prior Authorization Requirements

Generic trazodone rarely triggers prior authorization (PA) from commercial insurers in Missouri. PA is an insurer-mandated process requiring the prescriber to submit clinical documentation justifying the prescription before the pharmacy can dispense it. Because trazodone is inexpensive and available as a generic, most plans bypass PA entirely.

When PA is required, typically by Missouri Medicaid or certain managed-care Medicaid plans, the prescriber must submit documentation including the patient's diagnosis (ICD-10 code), prior treatment history (especially trials of sleep hygiene or CBT-I for insomnia claims), relevant lab results, and the prescribed dose and duration. The Missouri Department of Social Services publishes PA criteria on its MO HealthNet pharmacy page.

PA turnaround in Missouri ranges from 24 to 72 hours for standard requests. Urgent PA requests, defined as situations where delay could seriously jeopardize the patient's health, must be processed within 24 hours per federal Medicaid rules. If PA is denied, Missouri patients have the right to appeal through MO HealthNet's established appeals process.

Transferring a Trazodone Prescription to Missouri

Patients relocating to Missouri or visiting from another state can transfer an existing trazodone prescription to a Missouri pharmacy. Because trazodone is not a controlled substance, the transfer process is straightforward. The patient contacts a Missouri pharmacy, provides the originating pharmacy's information, and the receiving pharmacist initiates a prescription transfer per Missouri Board of Pharmacy rules.

Missouri accepts electronic prescription transfers between pharmacies in different states. The process typically completes within one business day. Patients should ensure they have at least a 7-day supply of medication on hand before initiating a transfer to avoid a gap in therapy.

For patients establishing new care in Missouri after relocating, bringing records of the original prescribing clinician's notes, the current dose, and the duration of therapy helps the new Missouri provider continue treatment without unnecessary re-evaluation. A telehealth visit with a Missouri-licensed provider can serve as the initial encounter to establish a new prescription if a transfer is not feasible.

Safety Considerations and Monitoring

Trazodone carries a boxed warning for suicidality risk in patients under 25, consistent with all antidepressants. The FDA's class-wide antidepressant warning applies regardless of the indication for which trazodone is prescribed.

The most common side effects at low doses include morning sedation, dizziness, and dry mouth. Priapism, a rare but serious adverse event, occurs in approximately 1 in 6,000 to 1 in 8,000 male patients according to published estimates. Missouri prescribers should counsel male patients about this risk and instruct them to seek emergency care if an erection persists beyond four hours.

Drug interactions warrant attention. Trazodone is metabolized primarily by CYP3A4, and concomitant use with strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) can increase trazodone plasma concentrations. Combining trazodone with other serotonergic medications raises the risk of serotonin syndrome, a potentially life-threatening condition. The FDA prescribing information recommends caution when co-prescribing trazodone with SSRIs, SNRIs, triptans, or MAO inhibitors.

Missouri prescribers should schedule a follow-up visit within 2 to 4 weeks of initiating trazodone to assess efficacy and tolerability. For patients using trazodone for insomnia, ongoing assessment every 3 to 6 months is reasonable to determine whether continued therapy is warranted or whether non-pharmacologic strategies can replace the medication.